Надеждина Е. А., Неряхин А. Д., Гафурова Р. Р., Рафикова Г. А., Еникеева К. И., Шарифьянова Ю. В., Акрамова Э. Р. Роль опухоль-ассоциированных макрофагов в канцерогенезе простаты. Медицинский вестник Башкортостана. 2024;19(4):80-85.
1. Рак предстательной железы. Клинические рекомендации / А.Д. Каприн [и др.] // Современная онкология. – 2021. – Т. 23, №2. – С. 211-247.
2. Сомов, А.Н. Рак предстательной железы. Эпидемиология, факторы риска и раннее выявление. / А.Н. Сомов, С.А. Суслин // Профилактическая медицина. – 2020. – Т. 23, №3. – С. 149-155.
3. Prevalence of incidental prostate cancer: A systematic review of autopsy studies / K.J. Bell [et al.] // Int.J. Cancer. – 2015. – Vol. 137, №7. – P. 1749-1757.
4. Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer / A. El-Kenawi [et al.] // Br.J. Cancer. – 2019. – Vol. 121, №7. – P. 556-566.
5. Ruffell, B. Macrophages and therapeutic resistance in cancer / B. Ruffell, L.M. Coussens // Cancer Cell. – 2015. – Vol. 27, № 4. – P. 462-472.
6. Rajabi, M. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer. / M. Rajabi, M. Adeyeye, S.A. Mousa // Curr. Med. Chem. – 2019. – Vol. 26, №30. – P. 5664-5683.
7. The Role of Macrophages in Cancer Development and Therapy / E. Cendrowicz [et al.] // Cancers (Basel). – 2021. – Vol. 13, №8 – P. 1946.
8. Boutilier, A.J. Macrophage Polarization States in the Tumor Microenvironment / A.J. Boutilier, S.F. Elsawa // Int. J. Mol. Sci. – 2021. – Vol. 22, №13. – P. 6995.
9. M2 macrophages and regulatory T cells in lethal prostate cancer. / A. Erlandsson [et al.] // Prostate. – 2019. – Vol. 79, №4. – P. 363-369.
10. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. / M. Masetti [et al.] // J. Exp. Med. – 2022. – Vol. 219, №2. – P. e20210564.
11. Xiao, L. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy. / L. Xiao, Q. Wang, H. Peng // Front. Immunol. – 2023. – Vol. 14. – P.1157291.
12. Роль Т-регуляторных клеток в прогрессировании рака предстательной железы / С.В. Попов [и др.] // Медицинская иммунология. – 2019. – Т. 21, №4. – С. 587-594.
13. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling / R. Huang [et al.] // Cell Death Dis. – 2020. – Vol. 11, №4. – P. 234.
14. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer / Y. Li [et al.] // Sci. Rep. – 2015. – Vol. 5. – P. 12495.
15. Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer / A. El-Kenawi [et al.] // Cancer Res. – 2021. – Vol. 81, №21. – P. 5477-5490.
16. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity / S.J. Kridel [et al.] // Cancer Res. – 2004. – Vol. 64, №6. – P. 2070-3005.
17. Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer / S. Balaban [et al.] // Mol. Cancer Res. – 2019. – Vol. 17, №4. – P. 949-962.
18. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer / M. Chen [et al.] // Nat. Genet. – 2018. – Vol. 50, № 2. – P. 206-218.
19. High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling / T. Hayashi [et al.] // Clin. Cancer Res. – 2018. – Vol. 24, №17. – P. 4309-4318.
20. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer / G. Llaverias [et al.] // Am.J. Pathol. – 2010. – Vol. 177, №6. – P. 3180-3191.
21. Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study / J. Jamnagerwalla [et al.] // Prostate Cancer Prostatic Dis. – 2018. – Vol. 21, №2. – P. 252-259.
22. Cholesterol and prostate cancer risk: a long-term prospective cohort study / T. Heir [et al.] // BMC Cancer. – 2016. – Vol. 16. – P. 643.
23. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada / A. Blanc-Lapierre [et al.] // BMC Public Health. – 2015. – Vol. 15. – P. 913.
24. Effect on cardiovascular risk of high-density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients / D. Keene [et al.] // BMJ. – 2014. – Vol. 349. – P. g4379.
25. Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies / L. YuPeng [et al.] // Cancer Epidemiol Biomarkers Prev. – 2015. – Vol. 24, №7. – P. 1086-1093.
26. The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake / Z. Zhang [et al.] // J.Biol. Chem. – 2021. – Vol. 296. – P. 100616.
27. PRACTICAL consortium. Blood lipids and prostate cancer: a Mendelian randomization analysis / C.J. Bull [et al.] // Cancer Med. – 2016. – Vol. 5, №6. – P. 1125-1136.
28. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages / H. Wu [et al.] // EMBO Mol. Med. – 2019. – Vol. 11, №11. – P. e10698.
29. Tumor-Associated Macrophages in Tumor Immunity / Y. Pan [et al.] // Front. Immunol. – 2020. – Vol. 11. – P. 583084.
30. Ковалева, О.В. Цитотоксическая активность макрофагов и ее роль в патогенезе опухолей / О.В. Ковалева, П.А. Подлесная, А.Н. Грачев // Альманах клинической медицины. – 2022. – Т. 50, №1. – С. 13-20.
31. Макрофаги, ассоциированные с опухолью: современное состояние исследований и перспективы клинического использования / А.Н. Грачев [и др.] // Успехи молекулярной онкологии. – 2018. – Т. 5, №4. – С. 20–8.
32. Yu, Y. Present and future of cancer immunotherapy: A tumor microenvironmental perspective / Y. Yu, J. Cui // Oncol. Lett. – 2018. – Vol. 16, №4. – P. 4105-4113.
33. The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention / H. Vahora [et al.] // J. Cancer Prev. – 2016. – Vol. 21, №1. – P. 1-12.
34. Макрофаги и опухолевая прогрессия: на пути к макрофаг-специфичной терапии / Н.В. Чердынцева [и др.] // Бюллетень сибирской медицины. – 2017. – Т. 16, №4. – С. 61–74.
